MCM
AZN icon

Mengis Capital Management’s AstraZeneca AZN Stock Holding History

Mengis Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.21M Buy
46,698
+17
+0% +$3.28K 1.59% 16
2025
Q4 		$8.58M Buy
46,681
+3,260
+8% +$572K 1.52% 16
2025
Q3 		$6.66M Buy
43,421
+6,991
+19% +$1.06M 1.31% 18
2025
Q2 		$5.09M Buy
36,430
+6,075
+20% +$851K 1.08% 21
2025
Q1 		$4.46M Buy
+30,355
New +$4.39M 0.93% 25

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Mengis Capital Management's AZN Position: Q1 2026 in Review

Mengis Capital Management increased its AstraZeneca (AZN) stake by 0.04% in Q1 2026, buying an estimated $3.28K and bringing the position to 46,698 shares worth $9.21M. The position accounts for 1.59% of the portfolio, ranked #16.

Mengis Capital Management first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Mengis Capital Management held 46,698 shares of AstraZeneca worth $9.21M as of Q1 2026.
  • Mengis Capital Management bought 17 AstraZeneca shares in Q1 2026, an estimated $3.28K.
  • AstraZeneca made up 1.59% of Mengis Capital Management's portfolio in Q1 2026, its #16 holding.
  • Mengis Capital Management first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.